Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-16

Clinical Trial Update: PraxbindTM India PMS Program

View source ↗

Summary

A clinical trial update for PraxbindTM India PMS Program indicating completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Praxbind (Idarucizumab)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism | Status: COMPLETED | Results posted: 2021-02-16